Table 6.

Outcomes not significantly different between exposure groups for all antimalarial types.^a

Neuropsychologic: Dementia, migraines, seizures, tinnitus, vestibular disorder, “other” neurologic disorder, “any” neurologic disorder

Cardiac: Arrhythmia, congestive heart failure, myocardial infarction, “any” cardiac disorder

Ophthalmologic: Macular degeneration, retinopathy, “any” ophthalmologic disorder

Dermatologic: Allergic dermatitis, eczema, psoriasis, “other” dermatologic condition, “any” dermatologic condition

Reproductive: Miscarriage

Gastrointestinal: Cirrhosis, esophageal ulceration, fatty liver, liver failure, peptic ulcer, “any” liver dysfunction

Infectious: Amebiasis, giardia, “other” gastrointestinal infection, “any” gastrointestinal infection

Hematologic/Oncologic: breast cancer, gastric cancer, leukemia, liver cancer, lymphoma, prostate cancer, “other” cancers, “any” cancer

^a“Any” means that the diagnoses previously listed were aggregated into one outcome.